share_log

Rapid Micro Biosystems Announces Publication Of A Multi-Author Case Study Supporting Fully Automated Colony Counting In Pharmaceutical Microbiology

Benzinga Real-time News ·  Dec 7, 2022 16:31

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company, providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, announced the publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment